Literature DB >> 6804089

Resistance to L1210 mouse leukemia cells in moderately protein-malnourished BALB/c mice treated in vivo with thymosin fraction V.

T M Petro, R R Watson.   

Abstract

Moderate protein malnutrition retarded the i.p. proliferation of L1210 mouse leukemia cells in BALB/c mice. The increased resistance against leukemia cell growth in protein-malnourished mice was correlated with increased in vitro mitogenic responsiveness of spleen lymphocytes to phytohemagglutinin and increased levels of serum corticosterone but could not be correlated with altered development of splenic lymphocyte-mediated cytotoxicity. The increased resistance against leukemia cells in well-fed mice treated with thymosin alone could not be correlated with an increase in any of these parameters. Treatment with Thymosin Fraction V further increased the resistance of protein-malnourished mice to i.p. leukemia cell growth. The increased resistance of these mice to tumor cell growth was correlated with increased splenic lymphocyte mitogenic responsiveness to phytohemagglutinin, elevated serum corticosterone levels, and a slight increase in lymphocyte-mediated cytotoxicity 14 days after tumor challenge. For 7 days after the last treatment, protein-malnourished mice had reduced serum corticosterone levels. Nevertheless, the serum corticosterone levels were still higher than normal in these mice.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6804089

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Activation of antitumor properties in alveolar macrophages from protein-calorie malnourished rats.

Authors:  S Mutsuura; S Sone; E Tsubura; K Tachibana; Y Kishino
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Immunomodulation and therapeutic characterization of thymosin fraction five.

Authors:  J E Talmadge; K A Uithoven; B F Lenz; M Chirigos
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  Alteration of cell-mediated immunity to Listeria monocytogenes in protein-malnourished mice treated with thymosin fraction V.

Authors:  T M Petro; G Chien; R R Watson
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

4.  Thymax, a gross thymic extract, exerts cell cycle arrest and apoptosis in Ehrlich ascites carcinoma in vivo.

Authors:  Nariman K Badr El-Din; Azza I Othman; Maggie E Amer; Mamdooh Ghoneum
Journal:  Heliyon       Date:  2022-03-05

Review 5.  Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications?

Authors:  P Samara; K Ioannou; O E Tsitsilonis
Journal:  Vitam Horm       Date:  2016-05-27       Impact factor: 3.421

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.